Literature DB >> 11801859

Issues surrounding age: vascular disease in the elderly.

J Shepherd1.   

Abstract

One-fifth of all humans who have survived beyond the age of 65 are alive today, and in the industrialized world the elderly segment of the population is expanding most rapidly. In biological terms, these survivors are healthier than the elderly of previous generations. However 'there are no diseases peculiar to old age and very few from which it is exempt' (Alfred Worcester, 1855-1951), and so society will inevitably accumulate a significant share of degenerative diseases within the ranks of its senior citizens. In the last two decades, the prevalence of stroke, diabetes mellitus, arthritis and heart disease has increased significantly as a tangible index of ageing in the population, and these diseases have been accompanied by degenerating cognitive function and physical disability, both of which are adding increasing stress to community healthcare and social services. Policy-makers need to understand and monitor these trends in order to make informed and cogent decisions about the management of this growing problem. This review highlights some of the key health issues facing the elderly in regard to coronary artery disease, insulin resistance, redox status, and statin therapy, in the hope that enlightened debate will inform decision making on resource allocation for this important and growing segment of society.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11801859     DOI: 10.1097/00041433-200112000-00002

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  3 in total

Review 1.  Statin therapy in the elderly: does it make good clinical and economic sense?

Authors:  Moira M B Mungall; Allan Gaw; James Shepherd
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

2.  Functional and molecular evidence of MaxiK channel beta1 subunit decrease with coronary artery ageing in the rat.

Authors:  Kazuhide Nishimaru; Mansoureh Eghbali; Rong Lu; Jure Marijic; Enrico Stefani; Ligia Toro
Journal:  J Physiol       Date:  2004-07-22       Impact factor: 5.182

3.  Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome.

Authors:  Paul Holvoet; Duk-Hee Lee; Michael Steffes; Myron Gross; David R Jacobs
Journal:  JAMA       Date:  2008-05-21       Impact factor: 56.272

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.